Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KDM6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BTN3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HLA-G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED12L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNDC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEBPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL7R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTUD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATS2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABARAPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on